Close

Credit Suisse Starts Amgen (AMGN) at Outperform, $205 PT

January 20, 2016 6:33 AM EST Send to a Friend
Credit Suisse initiates coverage on Amgen (NASDAQ: AMGN) with a Outperform rating and a price target of $205.00.Analyst Alethia Young ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login